Orly Hammer Munz

Title: Orly Hammer Munz: Innovator in Antimicrobial Testing

Introduction

Orly Hammer Munz is a notable inventor based in Ness Zionna, IL. She has made significant contributions to the field of antimicrobial susceptibility testing. Her innovative approach aims to enhance the speed and accuracy of determining antibiotic effectiveness against bacterial infections.

Latest Patents

Orly holds a patent for a method titled "Rapid antimicrobial susceptibility testing based on a unique spectral intensity ratio analysis via single fluorescence membrane dye staining and flow cytometry." This patent describes a technique that utilizes single dye fluorescent staining combined with differences in both intensity and spectral emission. This method allows for the determination of the minimum concentration of an antibiotic needed to inactivate bacteria, known as the Minimum Inhibitory Concentration (MIC). This rapid Antibiotic Susceptibility Testing (AST) method provides clinicians with a quick and effective means to establish suitable treatment regimens for patients suffering from bacterial infections, including those that may lead to sepsis.

Career Highlights

Orly is currently associated with Pocared Diagnostics Ltd., where she continues to develop innovative solutions in the medical diagnostics field. Her work focuses on improving patient outcomes through advanced testing methodologies.

Collaborations

Orly collaborates with esteemed colleagues, including Gal Ingber and Moshe Ben-David, to further enhance the impact of her inventions in the healthcare sector.

Conclusion

Orly Hammer Munz's contributions to antimicrobial susceptibility testing represent a significant advancement in medical diagnostics. Her innovative patent not only streamlines the testing process but also plays a crucial role in improving treatment strategies for bacterial infections.